Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Pervasive muscle response monitoring for everyone, a physiotherapy revolution

Project description

Novel product shows promise for the treatment of chronic pain

The EU-funded MDURANCE project is developing a diagnostic product for musculoskeletal disorders (MSD) that can rapidly analyse the complex data from non-invasive electromyographic (EMG) sensors and present them in an understandable format. EMG analysis allows visualisation of the electrical activity of the skeletal muscles and precise identification of muscle functionality. The product features unique data processing, it runs on the cloud, and it can generate results within five minutes with low-cost EMG sensors. Bringing this form of patient analysis to standard physiotherapy clinics will result in a much faster MSD diagnosis and properly prescribed and monitored rehabilitation exercises and processes.

Objective

Almost all of us have suffered a Musculoskeletal disorder (MSD) of some type or another. Whilst for several of us a back, or
neck ache can go with minor intervention, for many the problem can be chronic. Home life becomes a daily struggle, work
can not be completed and lively hoods are ruined.
At mDurance we have been developing a product that can rapidly analyse the complex data from non-invasive EMG
(Electromyographic) sensors and present this to physiotherapists in an understandable format. EMG analysis allows
visualisation of the electrical activity of the skeletal muscles in order to precisely pin-point which muscles are performing as
they should and which are not. Current solutions that attempt to do this needed custom adaptation to each patient and
situation, useful results take upto 45 minutes to generate and the costs are prohibitive for the overwhelming majority of
physiotherapists.
Based on the result of several years of research work and various scientific papers, mDurance has unique data processing
that generates results within 5minutes. Running in the cloud and using low-cost EMG sensors we are aiming to drive uptake
of this form of patient analysis to standard physiotherapist clinics. The result will be much faster MSD diagnosis and properly
targeted and monitored rehabilitation exercises and processes. Additionally, we also target Hospitals and other organisations
assessing the capacity of workers, as well as the sports market where we can increment athlete performance, better protect
against injury and decrease rehabilitation times.
The market is vast. There are over 1 million physiotherapy specialists worldwide and around 200,000 Health & Wellbeing
Centres plus professional and high performance sport clubs together worldwide. With a dedicated go-to-market plan, we aim
to take a 0.75% market share growing to 22 employees by 2023 and a total revenue of 10.76M Euros.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

SME-1 - SME instrument phase 1

See all projects funded under this funding scheme

Call for proposal

(opens in new window) H2020-EIC-SMEInst-2018-2020

See all projects funded under this call

Coordinator

MDURANCE SOLUTIONS SOCIEDAD LIMITAD
Net EU contribution
€ 50 000,00
Address
CL VIDRIOS DE SAN LAZARO 3 ESC.C 4-B
18012 Granada
Spain
SME
Yes
Region
Sur Andalucía Granada
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 71 429,00